ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      18,927.60
      -0.06%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      72.835
      0.63%
      Bitcoin
      61,964.46
      0.48%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. iRhythm Technologies Inc (IRTC) Quote

      iRhythm Technologies Inc

      iRhythm Technologies Inc (IRTC)

      NASDAQ
      71.03
      -0.48
      (-0.67%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      71.03
      0.00
      (0.00%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      71.03
      Bid
      67.48
      Ask
      76.91
      Volume
      457,864
      70.50 Day's Range 75.06
      60.88 52 Week Range 124.115
      Market Cap
      2.219B
      Previous Close
      71.51
      Open
      71.03
      Last Trade
      1
      @
      67.48
      Last Trade Time
      Financial Volume
      $ 32,835,588
      VWAP
      71.7147
      Average Volume (3m)
      474,751
      Shares Outstanding
      31,236,075
      Dividend Yield
      -
      PE Ratio
      -17.97
      Earnings Per Share (EPS)
      -3.95
      Revenue
      492.68M
      Net Profit
      -123.41M

      About iRhythm Technologies Inc

      iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The companys portfolio include ambulatory cardiac m... iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The companys portfolio include ambulatory cardiac monitoring services on a platform called the Zio service which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.irhythmtech.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      iRhythm Technologies Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker IRTC. The last closing price for iRhythm Technologies was $71.51. Over the last year, iRhythm Technologies shares have traded in a share price range of $ 60.88 to $ 124.115.

      iRhythm Technologies currently has 31,236,075 shares outstanding. The market capitalization of iRhythm Technologies is $2.23 billion. iRhythm Technologies has a price to earnings ratio (PE ratio) of -17.97.

      Ask ADVFN Intelligence (AI)

      IRTC Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      10 hours ago

      iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

      Zio ECG monitoring system is the only fourteen-day cardiac monitoring service in its category to receive Japanese regulatory approval as an improved device without a clinical trialZio ECG...

      September 11 2024
      GlobeNewswire Inc.

      iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

      iRhythm’s next-generation Zio® monitor demonstrated longer wear duration and analyzable time compared to the prior generation Zio® XT device.Longer wear duration and analyzable time may further...

      September 09 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 04 2024
      Edgar (US Regulatory)

      iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

      SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...

      September 04 2024
      GlobeNewswire Inc.

      Nvidia Subpoenaed by DOJ, Athira Pharma Shares Plunge 71% After Study Fails, Zscaler Falls 15% Post-Earnings

      Nvidia (NASDAQ:NVDA) – Nvidia’s stock closed down 9.5% on Tuesday, leading to a $279 billion loss in market value due to fading optimism over AI following weak economic data...

      September 04 2024
      IH Market News

      iRhythm Technologies Announces Results of GUARD-AF Trial

      GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024Leveraging iRhythm’s Zio® patch-based long-term continuous monitoring (LTCM), GUARD-AF is the largest...

      September 01 2024
      GlobeNewswire Inc.

      iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

      Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio® monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...

      August 29 2024
      GlobeNewswire Inc.

      iRhythm Technologies to Participate in Upcoming Investor Conferences in September

      SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...

      August 21 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      August 12 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.21-1.6749723145172.2477.9670.8132314174.11749555CS
      40.751.067159931770.2878.9260.8849698370.00463135CS
      12-29.81-29.5616818723100.84109.560.8847475178.25735504CS
      26-31.75-30.8912239735102.78118.4360.8844501091.13543838CS
      52-18.91-21.02512786389.94124.11560.8842152194.4228257CS
      1567.1411.175457818163.89169.5456.49398883109.26993867CS
      260-8.67-10.87829360179.7286.1941.6559426200113.57851629CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      OMEXOdyssey Marine Exploration Inc
      $ 1.39
      (180.07%)
      		328.86M
      PRTGPortage Biotech Inc
      $ 9.7581
      (115.41%)
      		51.53M
      APLTApplied Therapeutics Inc
      $ 7.86
      (69.03%)
      		51.66M
      XCHXCHG Ltd
      $ 18.40
      (65.77%)
      		1.26M
      WBUYWeBuy Global Ltd
      $ 0.1867
      (60.95%)
      		247.93M
      GLMDGalmed Pharmaceuticals Ltd
      $ 6.83
      (-54.77%)
      		6.24M
      KAKineta Inc
      $ 0.5691
      (-31.35%)
      		530.74k
      DTSSDatasea Inc
      $ 2.07
      (-29.59%)
      		1.34M
      CBUSCibus Inc
      $ 3.595
      (-28.95%)
      		2.31M
      BFIBurgerFi International Inc
      $ 0.1705
      (-26.98%)
      		16.55M
      OMEXOdyssey Marine Exploration Inc
      $ 1.39
      (180.07%)
      		328.86M
      NVDANVIDIA Corporation
      $ 113.37
      (-1.92%)
      		310.12M
      WBUYWeBuy Global Ltd
      $ 0.1867
      (60.95%)
      		247.93M
      SQQQProShares UltraPro Short QQQ
      $ 8.40
      (1.45%)
      		200.53M
      LUNRIntuitive Machines Inc
      $ 7.4512
      (37.99%)
      		141.82M

      IRTC Discussion

      View Posts
      jgrabar jgrabar 4 months ago
      Grabar Law Office is investigating whether the Board of Directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) ("iRhythm") breached their fiduciary duties to shareholders.

      If you have held iRhythm shares since prior to January 11, 2022, learn more at https://grabarlaw.com/the-latest/irhythm-shareholder-investigation/, or call Joshua H. Grabar at 267-507-6085.
      👍️0
      ollik78 ollik78 3 years ago
      Earnings today AH …
      👍️0
      BottomBounce BottomBounce 3 years ago
      $IRTC has $122.47M in debt
      👍️0
      crudeoil24 crudeoil24 3 years ago
      127.61 > hod.
      👍️0
      crudeoil24 crudeoil24 3 years ago
      iRhythm shares are trading higher following the release of the 2022 Medicare Physician Fee Schedule Final Rule by the Centers for Medicare and Medicaid Services.
      👍️0
      crudeoil24 crudeoil24 3 years ago
      iRhythm Technologies, Inc. is a digital healthcare company. It focuses on diagnosing cardiac arrhythmias by combining its wearable biosensing technology with cloud-based data analytics. It provides ambulatory electrocardiogram (ECG) monitoring for patients at risk for arrhythmias. It has created a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Its Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows.
      👍️0

      Your Recent History

      NASDAQ
      IRTC
      iRhythm Technologies
      Delayed Upgrade Clock